Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
9.29
+0.43 (4.85%)
At close: Jun 26, 2026, 4:00 PM EDT
9.10
-0.19 (-2.05%)
After-hours: Jun 26, 2026, 7:58 PM EDT
Solid Biosciences Employees
Solid Biosciences had 121 employees as of December 31, 2025. The number of employees increased by 21 or 21.00% compared to the previous year.
Employees
121
Change (1Y)
21
Growth (1Y)
21.00%
Revenue / Employee
n/a
Profits / Employee
-$1,584,959
Market Cap
914.60M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Replimune Group | 479 |
| Pharming Group | 407 |
| Janux Therapeutics | 108 |
| Annexon | 93 |
| Theravance Biopharma | 90 |
| Vor Biopharma | 76 |
| Alto Neuroscience | 68 |
| Avalo Therapeutics | 33 |
SLDB News
- 17 days ago - Solid Biosciences Transcript: AGM 2026 - Transcripts
- 19 days ago - Solid Biosciences Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 24 days ago - Solid Biosciences Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 25 days ago - Solid Biosciences price target raised to $25 from $20 at H.C. Wainwright - TheFly
- 26 days ago - Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 26 days ago - Solid Biosciences to Participate at Upcoming Investor Conferences - GlobeNewsWire
- 6 weeks ago - Solid Biosciences price target lowered to $16 from $17 at Wedbush - TheFly
- 6 weeks ago - Solid Biosciences price target raised to $18 from $17 at Piper Sandler - TheFly